Financial Performance - Net sales decreased 15% to 1.69billioncomparedtoa161.55, a decrease of 28% compared to the adjusted EPS of 2.16forthesameperiodin2023[31]−Thecompanyreportednetsalesof1,686 million for the three months ended Dec. 31, 2024, a 15% decrease from 1,990millioninthesameperiodof2023[36]−ThegrossprofitforthethreemonthsendedDec.31,2024,was738 million, down from 866millioninthesameperiodof2023[36]−TheadjustedEBITforthethreemonthsendedDec.31,2024,was258 million, a 33% decrease compared to 386millioninthesameperiodof2023[35]−TheHealthandWellnesssegmentreportednetsalesof628 million for the three months ended Dec. 31, 2024, a 13% decrease from 720millioninthesameperiodof2023[37]FutureOutlook−Thecompanyexpectsnetsalesforfiscalyear2025tobedown1105-115millionrelatedtodigitalcapabilitiesandproductivityenhancementsinfiscalyear2025[34]OperationalEfficiency−Year−to−datenetcashprovidedbyoperationswas401 million, representing a 132% increase compared to 173millionintheyear−agoperiod[4]−Cloroxachieveditsninthconsecutivequarterofgrossmarginexpansion,supportedbystrongcostsavings[6]−Grossmarginisexpectedtoincreaseby125to150basispoints,primarilyduetoholisticmarginmanagementefforts[9]InvestmentsandInnovations−Thecompanylaunchedseveralnewproducts,includingtheHiddenValleyRanchEasySqueezebottleandafullsuiteofBritaPluspitchersanddispensers[6]−CloroxwasrecognizedwithmultipleinnovationawardsforitsuseofAIinproductdevelopmentandsustainabilityefforts[6]−Thetotalincrementalinvestmentfordigitalcapabilitiesandproductivityenhancementsisprojectedtobebetween560 million and 580millionoverfiveyears,withapproximately7025 million in insurance recoveries related to the cyberattack during the three months ended December 31, 2024[31] - The company incurred cyberattack costs of 25millionforthethreemonthsendedDec.31,2024,netofinsurancerecoveries[35]FinancialPosition−Totalassetsdecreasedto5,577 million as of 12/31/2024, down from 5,751millionon6/30/2024and5,908 million on 12/31/2023[38] - Current liabilities increased to 1,730millionasof12/31/2024,comparedto1,574 million on 6/30/2024 and 2,022millionon12/31/2023[38]−Long−termdebtremainedstableat2,483 million as of 12/31/2024, slightly up from 2,481millionon6/30/2024and2,479 million on 12/31/2023[38] - Stockholders' equity showed a significant decline to 121millionasof12/31/2024,downfrom492 million on 6/30/2024 and 218millionon12/31/2023[38]−Cashandcashequivalentsincreasedto290 million as of 12/31/2024, up from 202millionon6/30/2024butdownfrom355 million on 12/31/2023[38] - Receivables decreased to 603millionasof12/31/2024,comparedto695 million on 6/30/2024 and 679millionon12/31/2023[38]−Inventoriesdecreasedto592 million as of 12/31/2024, down from 637millionon6/30/2024and655 million on 12/31/2023[38] - Total current assets slightly increased to 1,632millionasof12/31/2024,comparedto1,622 million on 6/30/2024 but down from 1,804millionon12/31/2023[38]−Thecompanyreportedaretainedearningsof68 million as of 12/31/2024, a decrease from 250millionon6/30/2024and241 million on 12/31/2023[38] - Total liabilities decreased to 5,456millionasof12/31/2024,downfrom5,259 million on 6/30/2024 and 5,690millionon12/31/2023[38]Divestitures−ThecompanycompletedthedivestitureofitsBetterHealthVMSbusiness,whichisexpectedtosupportitsIGNITEstrategyandimprovesalesgrowthandmargins[22]−Thecompanyreportedalossondivestitureof118 million related to the Better Health VMS business during the six months ended Dec. 31, 2024[34]